Small Molecular Immune Modulators as Anticancer Agents-Reference-Cited by-同舟云学术

Small Molecular Immune Modulators as Anticancer Agents

Published:2020 Issue: Volume: Page:547-618
ISSN:0065-2598
Container-title:Advances in Experimental Medicine and Biology
language:
Short-container-title:

Author:

Han Yongxin,Zhu Li,Wu Wei,Zhang Hui,Hu Wei,Dai Liguang,Yang Yanqing

Publisher

Springer Singapore

Link

http://link.springer.com/content/pdf/10.1007/978-981-15-3266-5_22

Reference337 articles.

1. A study of SHR-1210 in combination with apatinib in advanced non-small cell lung cancer (NSCLC) (2017). https://www.clinicaltrials.gov/ct2/show/NCT03083041?term=NCT03083041&rank=1 . Accessed 10 Sept 2019

2. Abdel-Magid AF (2015) Inhibitors of the PD-1/PD-L1 pathway can mobilize the immune system: an innovative potential therapy for cancer and chronic infections. ACS Med Chem Lett 6(5):489–490

3. Achek A, Yesudhas D, Choi S (2016) Toll-like receptors: promising therapeutic targets for inflammatory diseases. Arch Pharmacal Res 39(8):1032–1049

4. Acurio J, Troncoso F, Bertoglia P, Salomon C, Aguayo C, Sobrevia L et al (2014) Potential role of A2B adenosine receptors on proliferation/migration of fetal endothelium derived from preeclamptic pregnancies. Biomed Res Int 2014:274507

5. Adams S (2009) Toll-like receptor agonists in cancer therapy. Immunotherapy 1(6):949–964

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current strategies for targeting HPK1 in cancer and the barriers to preclinical progress;Expert Opinion on Therapeutic Targets;2024-04-02

2. M335, a novel small-molecule STING agonist activates the immune response and exerts antitumor effects;European Journal of Medicinal Chemistry;2024-01

3. Synergetic effect of matrine on the catalytic scFv antibody HS72 in vitro and in mice with Alzheimer disease pathology;Neuropharmacology;2024-01

4. Novel biomarkers used for early diagnosis and tyrosine kinase inhibitors as targeted therapies in colorectal cancer;Frontiers in Pharmacology;2023-09-01

5. Immunotherapy: Reshape the Tumor Immune Microenvironment;Frontiers in Immunology;2022-07-06